These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21692471)

  • 21. A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice.
    Jin CH; Chae SY; Son S; Kim TH; Um KA; Youn YS; Lee S; Lee KC
    J Control Release; 2009 Feb; 133(3):172-7. PubMed ID: 18977255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosimetry of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 in rodents, pigs, non-human primates and human - repeated scanning in human is possible.
    Selvaraju RK; Bulenga TN; Espes D; Lubberink M; Sörensen J; Eriksson B; Estrada S; Velikyan I; Eriksson O
    Am J Nucl Med Mol Imaging; 2015; 5(3):259-69. PubMed ID: 26069859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninvasive Imaging of Islet Transplants with 111In-Exendin-3 SPECT/CT.
    van der Kroon I; Andralojc K; Willekens SM; Bos D; Joosten L; Boerman OC; Brom M; Gotthardt M
    J Nucl Med; 2016 May; 57(5):799-804. PubMed ID: 26795287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of exendin-4-conjugated superparamagnetic iron oxide nanoparticles in beta-cell-targeted MRI.
    Zhang B; Yang B; Zhai C; Jiang B; Wu Y
    Biomaterials; 2013 Jul; 34(23):5843-52. PubMed ID: 23642536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of
    Kimura H; Ogawa Y; Fujimoto H; Mukai E; Kawashima H; Arimitsu K; Toyoda K; Fujita N; Yagi Y; Hamamatsu K; Murakami T; Murakami A; Ono M; Nakamoto Y; Togashi K; Inagaki N; Saji H
    Bioorg Med Chem; 2018 Jan; 26(2):463-469. PubMed ID: 29273416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PET of insulinoma using ¹⁸F-FBEM-EM3106B, a new GLP-1 analogue.
    Gao H; Niu G; Yang M; Quan Q; Ma Y; Murage EN; Ahn JM; Kiesewetter DO; Chen X
    Mol Pharm; 2011 Oct; 8(5):1775-82. PubMed ID: 21800885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice.
    Kim SJ; Nian C; Doudet DJ; McIntosh CH
    Diabetes; 2008 May; 57(5):1331-9. PubMed ID: 18299314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exendin-4 increases the expression of hypoxia-inducible factor-1α in rat islets and preserves the endocrine cell volume of both free and macroencapsulated islet grafts.
    Jia X; Sharma A; Kumagai-Braesch M; Wernerson AM; Sörenby AK; Yamamoto S; Wang F; Tibell AB
    Cell Transplant; 2012; 21(6):1269-83. PubMed ID: 22405036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of
    Kimura H; Matsuda H; Ogawa Y; Fujimoto H; Toyoda K; Fujita N; Arimitsu K; Hamamatsu K; Yagi Y; Ono M; Inagaki N; Saji H
    Bioorg Med Chem; 2017 Feb; 25(4):1406-1412. PubMed ID: 28089587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-Activity Relationships and Pharmacokinetics of
    Iikuni S; Ohara T; Watanabe H; Ono M
    Mol Pharm; 2022 Aug; 19(8):2832-2839. PubMed ID: 35757958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma.
    Wicki A; Wild D; Storch D; Seemayer C; Gotthardt M; Behe M; Kneifel S; Mihatsch MJ; Reubi JC; Mäcke HR; Christofori G
    Clin Cancer Res; 2007 Jun; 13(12):3696-705. PubMed ID: 17575235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ex vivo imaging of pancreatic beta cells using a radiolabeled GLP-1 receptor agonist.
    Connolly BM; Vanko A; McQuade P; Guenther I; Meng X; Rubins D; Waterhouse R; Hargreaves R; Sur C; Hostetler E
    Mol Imaging Biol; 2012 Feb; 14(1):79-87. PubMed ID: 21394533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
    Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
    Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving the Theranostic Potential of Exendin 4 by Reducing the Renal Radioactivity through Brush Border Membrane Enzyme-Mediated Degradation.
    Zhang M; Jacobson O; Kiesewetter DO; Ma Y; Wang Z; Lang L; Tang L; Kang F; Deng H; Yang W; Niu G; Wang J; Chen X
    Bioconjug Chem; 2019 Jun; 30(6):1745-1753. PubMed ID: 31181890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.
    Wild D; Wicki A; Mansi R; Béhé M; Keil B; Bernhardt P; Christofori G; Ell PJ; Mäcke HR
    J Nucl Med; 2010 Jul; 51(7):1059-67. PubMed ID: 20595511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 18F-radiolabeled GLP-1 analog exendin-4 for PET/CT imaging of insulinoma in small animals.
    Wu H; Liang S; Liu S; Pan Y; Cheng D; Zhang Y
    Nucl Med Commun; 2013 Jul; 34(7):701-8. PubMed ID: 23652208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and preclinical characterization of [64Cu]NODAGA-MAL-exendin-4 with a Nε-maleoyl-L-lysyl-glycine linkage.
    Yim CB; Mikkola K; Fagerholm V; Elomaa VV; Ishizu T; Rajander J; Schlesinger J; Roivainen A; Nuutila P; Solin O
    Nucl Med Biol; 2013 Nov; 40(8):1006-12. PubMed ID: 23932646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new technique for in vivo imaging of specific GLP-1 binding sites: first results in small rodents.
    Gotthardt M; Lalyko G; van Eerd-Vismale J; Keil B; Schurrat T; Hower M; Laverman P; Behr TM; Boerman OC; Göke B; Béhé M
    Regul Pept; 2006 Dec; 137(3):162-7. PubMed ID: 16930741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of an
    Iikuni S; Kamei I; Ohara T; Watanabe H; Ono M
    Mol Pharm; 2022 Mar; 19(3):1019-1027. PubMed ID: 35138111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of exendin-4 on beta-cell replication in mouse and human islet grafts.
    Tian L; Gao J; Weng G; Yi H; Tian B; O'Brien TD; Guo Z
    Transpl Int; 2011 Aug; 24(8):856-64. PubMed ID: 21627696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.